UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Fiduciary Group LLC

Fiduciary Group LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 7.3% during the second quarter, HoldingsChannel reports. The fund owned 3,657 shares of the healthcare conglomerate’s stock after purchasing an additional 249 shares during the period. Fiduciary Group LLC’s holdings in UnitedHealth Group were worth $1,949,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Urban Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $29,000. Knott David M Jr purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $29,000. Rothschild & Co Wealth Management UK Ltd purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Enterprise Trust & Investment Co purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $39,000. Finally, WFA of San Diego LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $41,000. Hedge funds and other institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Trading Up 1.3 %

UNH stock traded up $6.62 during trading on Thursday, reaching $529.71. 2,238,349 shares of the stock traded hands, compared to its average volume of 3,418,937. The business’s 50 day moving average price is $524.05 and its 200-day moving average price is $515.70. UnitedHealth Group Incorporated has a 52-week low of $438.21 and a 52-week high of $558.10. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.82 and a quick ratio of 0.82. The firm has a market capitalization of $494.93 billion, a PE ratio of 25.94, a P/E/G ratio of 1.63 and a beta of 0.75.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, October 14th. The healthcare conglomerate reported $5.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.45 by $0.34. The firm had revenue of $80.89 billion during the quarter, compared to the consensus estimate of $80.54 billion. UnitedHealth Group had a return on equity of 26.59% and a net margin of 6.17%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.52 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 22.01 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th will be paid a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date of this dividend is Friday, December 2nd. UnitedHealth Group’s dividend payout ratio is presently 32.32%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. SVB Leerink dropped their price target on UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating on the stock in a research note on Monday, October 17th. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $569.00 to $615.00 and gave the company a “buy” rating in a research note on Tuesday, October 18th. StockNews.com started coverage on UnitedHealth Group in a research note on Wednesday, October 12th. They issued a “strong-buy” rating on the stock. Raymond James downgraded UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 target price on the stock. in a research note on Monday. Finally, Mizuho lifted their target price on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $595.11.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.